Isomorphic Labs Appoints Dr. Ben Wolf as Chief Medical Officer

Isomorphic Labs has appointed Dr. Ben Wolf as Chief Medical Officer and established a new US presence in Cambridge, Massachusetts, announced in a press release. Dr. Wolf, who brings nearly 20 years of biopharmaceutical experience, will lead the company's efforts in translating AI-driven drug discoveries into medicines.

Dr. Wolf will be based in the newly established Cambridge location, which will serve as a key operational hub. This expansion follows the company's recent $600 million funding round, aimed at advancing its AI drug design engine. Dr. Wolf's previous roles include Chief Medical Officer at Relay Therapeutics and KSQ Therapeutics, where he led clinical trials and advanced therapeutic pipelines.

The appointment of Dr. Wolf and the establishment of the US presence underscore Isomorphic Labs' commitment to leveraging AI for drug discovery and development. The Cambridge hub will work closely with teams in London and Lausanne, enhancing the company's global operations.